Our Team at CPHI Milan 2026
About Anthea Pharma
Anthea Pharma, established in 2019 is a young, R&D focused Injectables firm, backed by the prestigious Yashoda Group. Based out of Hyderabad, India, Anthea Pharma has a world class R&D facility, and an injectable manufacturing facility, currently capable of manufacturing liquid Vials, Emulsions, PFS, Lyophilized Vials and Ampoules. Anthea Pharma envisions to manufacture for the world and be a global firm focused on injectables needs with consistent supply of highest-quality products across therapeutic segments. Our deep relationships in the healthcare and life science segment has enabled us to secure the backing of Yashoda Group, weaving a compelling blend of Hospitals, Pharmaceuticals, and Real Estate.
About CPHI Milan 2026
With a focus on fostering innovation and collaboration, CPHI Milan brings together key players across the pharmaceutical and biotech industries & offers attendees a unique opportunity to explore cutting-edge technologies, products, and services that are shaping the future of pharmaceuticals.
Key Highlights of CPHI Milan 2026:
Global Participation: The event expects to welcome 60,000+ attendees and 2,400+ exhibitors from 168+ countries, demonstrating its significant international reach.
Diverse Exhibition: Attendees can explore a wide range of products and services across various pharmaceutical sectors.
Networking Opportunities: CPHI Milan offers numerous opportunities for attendees to connect, build relationships, and forge partnerships.
Celebration of over 35 Years: CPHI Milan 2026 marks a special milestone, celebrating over 35 years of uniting the pharma community.










